Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 1
2013 1
2014 1
2015 1
2017 3
2018 2
2019 7
2020 7
2021 8
2022 7
2023 6
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Mucosal Microbiota from Colorectal Cancer, Adenoma and Normal Epithelium Reveals the Imprint of Fusobacterium nucleatum in Cancerogenesis.
Palmieri O, Castellana S, Latiano A, Latiano T, Gentile A, Panza A, Nardella M, Ciardiello D, Latiano TP, Corritore G, Mazza T, Perri F, Biscaglia G. Palmieri O, et al. Among authors: latiano tp. Microorganisms. 2023 Apr 28;11(5):1147. doi: 10.3390/microorganisms11051147. Microorganisms. 2023. PMID: 37317121 Free PMC article.
Counteracting gemcitabine+nab-paclitaxel induced dysbiosis in KRAS wild type and KRASG12D mutated pancreatic cancer in vivo model.
Panebianco C, Pisati F, Villani A, Andolfo A, Ulaszewska M, Bellini E, Ferro C, Lombardi R, Orsenigo F, Latiano TP, Belmonte B, Tripodo C, Perri F, Pazienza V. Panebianco C, et al. Among authors: latiano tp. Cell Death Discov. 2023 Apr 5;9(1):116. doi: 10.1038/s41420-023-01397-y. Cell Death Discov. 2023. PMID: 37019893 Free PMC article.
Efficacy and safety of a biomarker-driven cetuximab-based treatment regimen over 3 treatment lines in mCRC patients with RAS/BRAF wild type tumors at start of first line: The CAPRI 2 GOIM trial.
Martini G, Ciardiello D, Napolitano S, Martinelli E, Troiani T, Latiano TP, Avallone A, Normanno N, Di Maio M, Maiello E, Ciardiello F. Martini G, et al. Among authors: latiano tp. Front Oncol. 2023 Feb 13;13:1069370. doi: 10.3389/fonc.2023.1069370. eCollection 2023. Front Oncol. 2023. PMID: 36860319 Free PMC article.
Trop-2 and Nectin-4 immunohistochemical expression in metastatic colorectal cancer: searching for the right population for drugs' development.
Moretto R, Germani MM, Giordano M, Conca V, Proietti A, Niccoli C, Pietrantonio F, Lonardi S, Tamburini E, Zaniboni A, Passardi A, Latiano TP, Fanotto V, Di Donato S, Prisciandaro M, Bergamo F, Masi G, Fontanini G, Ugolini C, Cremolini C. Moretto R, et al. Among authors: latiano tp. Br J Cancer. 2023 Mar;128(7):1391-1399. doi: 10.1038/s41416-023-02180-7. Epub 2023 Feb 9. Br J Cancer. 2023. PMID: 36759721 Free PMC article. Clinical Trial.
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey.
Reni M, Giommoni E, Bergamo F, Milella M, Cavanna L, Di Marco MC, Spada M, Cordio S, Aprile G, Cardellino GG, Maiello E, Bernardini I, Ghidini M, Bozzarelli S, Macchini M, Orsi G, De Simone I, Rulli E, Porcu L, Torri V, Pinto C; GARIBALDI Study Group. Reni M, et al. ESMO Open. 2023 Feb;8(1):100777. doi: 10.1016/j.esmoop.2022.100777. Epub 2023 Feb 1. ESMO Open. 2023. PMID: 36731325 Free PMC article.
Correction: Ciardiello et al. Biomarker-Guided Anti-EGFR Rechallenge Therapy in Metastatic Colorectal Cancer. Cancers 2021, 13, 1941.
Ciardiello D, Martini G, Famiglietti V, Napolitano S, De Falco V, Troiani T, Latiano TP, Ros J, Elez Fernandez E, Vitiello PP, Maiello E, Ciardiello F, Martinelli E. Ciardiello D, et al. Among authors: latiano tp. Cancers (Basel). 2022 Aug 12;14(16):3900. doi: 10.3390/cancers14163900. Cancers (Basel). 2022. PMID: 36011056 Free PMC article.
Butyrate, a postbiotic of intestinal bacteria, affects pancreatic cancer and gemcitabine response in in vitro and in vivo models.
Panebianco C, Villani A, Pisati F, Orsenigo F, Ulaszewska M, Latiano TP, Potenza A, Andolfo A, Terracciano F, Tripodo C, Perri F, Pazienza V. Panebianco C, et al. Among authors: latiano tp. Biomed Pharmacother. 2022 Jul;151:113163. doi: 10.1016/j.biopha.2022.113163. Epub 2022 May 24. Biomed Pharmacother. 2022. PMID: 35617803 Free article.
Immunotherapy in advanced anal cancer: Is the beginning of a new era?
Ciardiello D, Guerrera LP, Maiorano BA, Parente P, Latiano TP, Di Maio M, Ciardiello F, Troiani T, Martinelli E, Maiello E. Ciardiello D, et al. Among authors: latiano tp. Cancer Treat Rev. 2022 Apr;105:102373. doi: 10.1016/j.ctrv.2022.102373. Epub 2022 Mar 8. Cancer Treat Rev. 2022. PMID: 35279535 Review.
38 results